Effects of Different Pulmonary Vasodilators on Arterial Saturation in a Model of Pulmonary Hypertension

Open Access

Peer-reviewed

Research Article

Eva Maria Becker ,

* E-mail: eva.becker1@bayer.com

Affiliations Bayer Pharma AG, Cardiology Research, Wuppertal, Germany, University Witten/Herdecke, Fakultät für Gesundheit, Witten, Germany
⨯
Johannes-Peter Stasch,

Affiliations Bayer Pharma AG, Cardiology Research, Wuppertal, Germany, Institute of Pharmacy, Martin Luther University Halle, Germany
⨯
Martin Bechem,

Affiliation Bayer Pharma AG, Cardiology Research, Wuppertal, Germany
⨯
Jörg Keldenich,

Affiliation Bayer Pharma AG, Cardiology Research, Wuppertal, Germany
⨯
Alexandra Klipp,

Affiliation Bayer Pharma AG, Cardiology Research, Wuppertal, Germany
⨯
Katja Schaefer,

Affiliation Bayer Pharma AG, Cardiology Research, Wuppertal, Germany
⨯
Hannes-Friedrich Ulbrich,

Affiliation Bayer Pharma AG, Research and Industrial Statistics, Berlin, Germany
⨯
Hubert Truebel

Affiliations Bayer Pharma AG, Cardiology Research, Wuppertal, Germany, University Witten/Herdecke, Fakultät für Gesundheit, Witten, Germany
⨯

Reader Comments (0)

Vasodilators
Is the Subject Area "Vasodilators" applicable to this article?

Thanks for your feedback.
Blood pressure
Is the Subject Area "Blood pressure" applicable to this article?

Thanks for your feedback.
Medical hypoxia
Is the Subject Area "Medical hypoxia" applicable to this article?

Thanks for your feedback.
Oxygen
Is the Subject Area "Oxygen" applicable to this article?

Thanks for your feedback.
Hemoglobin
Is the Subject Area "Hemoglobin" applicable to this article?

Thanks for your feedback.
Hemodynamics
Is the Subject Area "Hemodynamics" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Pulmonary arteries
Is the Subject Area "Pulmonary arteries" applicable to this article?

Thanks for your feedback.